Why Pristyn Care is losing favour with doctors and hospitals

Accused of pushing for unnecessary surgical procedures, the health tech startup now faces a backlash and the prospect of regulatory action.

13 July, 202212 min
0
Google Preferred Source Badge
Share
Getting your Trinity Audio player ready...
Why Pristyn Care is losing favour with doctors and hospitals

Why read this story?

Editor's note: On a Monday morning earlier this year, A was scheduled to perform haemorrhoid surgery on a 50-year-old man. For a few weeks, the patient had been experiencing bleeding and painful bowel movements, and he had eventually reached out to the online surgery care platform, Pristyn Care, for treatment. In initial consultations with the Pristyn Care team, for whom proctology cases are a regular affair, the patient had been told he’d need surgery. But a day before the procedure, during a pre-op consultation with the patient, A realized that surgery wasn’t really required and that the problem could be treated with medication.  It should have been a simple decision for the doctor, who is in his early 40s and has been practising for about 15 years. Instead, he was at a crossroads. Cancelling the surgery would jeopardize his ties with the company. It had only been a couple of months since he’d joined Pristyn Care, during which he’d conducted about 10 procedures. The brief when he joined was clear: The more surgeries he’d perform, the more leads he would get. The …

You may also like

Business
Story image

Why Healthcare is the new management frontier

Healthcare is one of the fastest growing sectors. For young professionals, the sector offers a spectrum of opportunities beyond medicine, spanning hospital operations, data analytics, corporate strategy, and digital health.

Internet
Story image

In Indian VC landscape, capital outpaces opportunity

The country’s top VC funds are flush with new fundraises. They must now find opportunities to invest, but that’s easier said than done.

Internet
Story image

What Pronto’s $25-million fundraise isn’t telling us

The 10-minute house help startup has generated plenty of buzz. But its funding, valuation and founder dilution details suggest a complicated future.